Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boris Zhivotovsky

Showing results (21-30 of 225) with videos related to

Pageof 23
Sort By:
Seminars in Cancer Biology|January 24, 2009
The Warburg Effect returns to the cancer stageBoris Zhivotovsky, Sten Orrenius
Cell Cycle (Georgetown, Tex.)|January 24, 2009
Do checkpoint kinases contribute to HIV-1-mediated apoptosis?Helin Vakifahmetoglu, Boris Zhivotovsky
Nature Chemical Biology|January 13, 2006
Cardiolipin oxidation sets cytochrome c freeSten Orrenius, Boris Zhivotovsky
Apoptosis : an International Journal on Programmed Cell Death|February 25, 2009
Clinical perspectives of cell death: where we are and where to goBoris Zhivotovsky, Sten Orrenius
Mitochondrion|October 16, 2014
Mitochondria--a bullseye in cancer therapyVladimir Gogvadze, Boris Zhivotovsky
Biochemical and Biophysical Research Communications|November 7, 2022
Programmed cell death: Past, present and futureGelina S Kopeina, Boris Zhivotovsky
Current Pharmaceutical Design|December 16, 2006
Role of alterations in the apoptotic machinery in sensitivity of cancer cells to treatmentSalvador Rodriguez-Nieto, Boris Zhivotovsky
Cancer Biology & Therapy|January 31, 2004
Guarding the Bcl-2 armyJan Schmidt-Mende, Boris Zhivotovsky
Cell Cycle (Georgetown, Tex.)|November 14, 2002
New methodology is a key to progressJohn D Robertson, Boris Zhivotovsky
Oncogene|April 13, 2004
DNA damage-induced apoptosisChris J Norbury, Boris Zhivotovsky
Pageof 23

Showing results (21-30 of 225) with videos related to

Sort By:
Pageof 23
Seminars in Cancer Biology|January 24, 2009
The Warburg Effect returns to the cancer stageBoris Zhivotovsky, Sten Orrenius
Cell Cycle (Georgetown, Tex.)|January 24, 2009
Do checkpoint kinases contribute to HIV-1-mediated apoptosis?Helin Vakifahmetoglu, Boris Zhivotovsky
Nature Chemical Biology|January 13, 2006
Cardiolipin oxidation sets cytochrome c freeSten Orrenius, Boris Zhivotovsky
Apoptosis : an International Journal on Programmed Cell Death|February 25, 2009
Clinical perspectives of cell death: where we are and where to goBoris Zhivotovsky, Sten Orrenius
Mitochondrion|October 16, 2014
Mitochondria--a bullseye in cancer therapyVladimir Gogvadze, Boris Zhivotovsky
Biochemical and Biophysical Research Communications|November 7, 2022
Programmed cell death: Past, present and futureGelina S Kopeina, Boris Zhivotovsky
Current Pharmaceutical Design|December 16, 2006
Role of alterations in the apoptotic machinery in sensitivity of cancer cells to treatmentSalvador Rodriguez-Nieto, Boris Zhivotovsky
Cancer Biology & Therapy|January 31, 2004
Guarding the Bcl-2 armyJan Schmidt-Mende, Boris Zhivotovsky
Cell Cycle (Georgetown, Tex.)|November 14, 2002
New methodology is a key to progressJohn D Robertson, Boris Zhivotovsky
Oncogene|April 13, 2004
DNA damage-induced apoptosisChris J Norbury, Boris Zhivotovsky
Pageof 23